ArticleEuropean heart journal2021
Cardiovascular magnetic resonance imaging in suspected cardiac tumour: a multicentre outcomes study.
Article in European heart journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 53 citations in OpenAlex.
- Case report: aortic root thrombus presenting with syncope and embolic events.European heart journal. Case reports · 2026Article
- Multiparametric cardiovascular magnetic resonance for differentiating cardiac masses: clinical impact from a case series.European heart journal. Case reports · 2026Article
- Review
- Case Report: Leiomyosarcoma of the inferior vena cava presenting as a right atrial mass: the value of multimodality imaging.Frontiers in cardiovascular medicine · 2026Article
- Article
- A Multi-Modality Approach to the Assessment of a Right Atrium Mass in a Female Patient with Breast Cancer Undergoing Neoadjuvant Chemotherapy.Diagnostics (Basel, Switzerland) · 2025Article
- Excessive left ventricular trabeculations mimicking a thrombus.European heart journal. Case reports · 2025Article
- A Dynamic Multimodality Imaging Assessment of Right Ventricular Thrombosis in a Middle-Aged Man with Lymphocytic Interstitial Pneumonia: The Additive Role of Tissue Doppler Imaging.Journal of clinical medicine · 2025Article
- Development and validation of a novel echocardiography-based nomogram for the streamlined classification of cardiac tumors in cancer patients.Quantitative imaging in medicine and surgery · 2025Article
- Evolution of left ventricular thrombus on serial cardiovascular magnetic resonance imaging.European heart journal. Cardiovascular Imaging · 2025Article
- Case report and diagnostic implications of misdiagnosis of pericardial myxoid liposarcoma by multimodal imaging.Frontiers in cardiovascular medicine · 2025Article
- Multimodal cardiac imaging and endoscopic ultrasound-guided fine needle aspiration for accurate diagnosis and management of giant primary pericardial schwannoma: a case report with literature review.Frontiers in cardiovascular medicine · 2025Article
- Cardiac Involvement in Metastatic Melanoma: Diagnostic Insights From Cardiac Imaging.JACC. Case reports · 2025Article
- Calcified Amorphous Tumor and Granulomatosis with Polyangiitis-Case Report and Systematic Review of the Literature.Journal of clinical medicine · 2024Review
- Multimodality Imaging in the Diagnostic Work-Up of Patients With Cardiac Masses:JACC. CardioOncology · 2024Review
- Cardiac Computed Tomography as a Method of Diagnosing the Type of Cardiac Tumor-Example of Interatrial Septal Lipoma Filling the Right Atrium.Diagnostics (Basel, Switzerland) · 2024Article
- Cardiac Magnetic Resonance to Predict Cardiac Mass Malignancy: The CMR Mass Score.Circulation. Cardiovascular imaging · 2024Observational
- Incremental Utility of First-Pass Perfusion CMR for Prognostic Risk Stratification of Cancer-Associated Cardiac Masses.JACC. Cardiovascular imaging · 2024Article
- Case Report: A rare diffuse mitral valvular myxoma.Frontiers in cardiovascular medicine · 2024Article
- Case Report: Multimodality imaging of a bronchogenic cyst in the interatrial septum.Frontiers in cardiovascular medicine · 2024Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
9 authors at 4 institutions in 1 country.
Funding
Abstract
aimsCardiovascular magnetic resonance (CMR) imaging is a key diagnostic tool for the evaluation of patients with suspected cardiac tumours. Patient management is guided by the CMR diagnosis, including no further testing if a mass is excluded or if only a pseudomass is found. However, there are no outcomes studies validating this approach. METHODS AND
resultsIn this multicentre study of patients undergoing clinical CMR for suspected cardiac tumour, CMR diagnoses were assigned as no mass, pseudomass, thrombus, benign tumour, or malignant tumour. A final diagnosis was determined after follow-up using all available data. The primary endpoint was all-cause mortality. Among 903 patients, the CMR diagnosis was no mass in 25%, pseudomass in 16%, thrombus in 16%, benign tumour in 17%, and malignant tumour in 23%. Over a median of 4.9 years, 376 patients died. Compared with the final diagnosis, the CMR diagnosis was accurate in 98.4% of patients. Patients with CMR diagnoses of pseudomass and benign tumour had similar mortality to those with no mass, whereas those with malignant tumour [hazard ratio (HR) 3.31 (2.40-4.57)] and thrombus [HR 1.46 (1.00-2.11)] had greater mortality. The CMR diagnosis provided incremental prognostic value over clinical factors including left ventricular ejection fraction, coronary artery disease, and history of extracardiac malignancy (P < 0.001).
conclusionIn patients with suspected cardiac tumour, CMR has high diagnostic accuracy. Patients with CMR diagnoses of no mass, pseudomass, and benign tumour have similar long-term mortality. The CMR diagnosis is a powerful independent predictor of mortality incremental to clinical risk factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.